BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 27888799)

  • 1. New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status.
    Altaf M; Monim-Ul-Mehboob M; Kawde AN; Corona G; Larcher R; Ogasawara M; Casagrande N; Celegato M; Borghese C; Siddik ZH; Aldinucci D; Isab AA
    Oncotarget; 2017 Jan; 8(1):490-505. PubMed ID: 27888799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming cisplatin resistance using gold(III) mimics: anticancer activity of novel gold(III) polypyridyl complexes.
    Palanichamy K; Sreejayan N; Ontko AC
    J Inorg Biochem; 2012 Jan; 106(1):32-42. PubMed ID: 22112837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: solution behavior, reactions with model proteins, antiproliferative properties.
    Maiore L; Cinellu MA; Nobili S; Landini I; Mini E; Gabbiani C; Messori L
    J Inorg Biochem; 2012 Mar; 108():123-7. PubMed ID: 22173093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts.
    Milacic V; Chen D; Ronconi L; Landis-Piwowar KR; Fregona D; Dou QP
    Cancer Res; 2006 Nov; 66(21):10478-86. PubMed ID: 17079469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization, and antitumor activity of unusual pseudo five coordinate gold(III) complexes: distinct cytotoxic mechanism or expensive ligand delivery systems?
    Olsen PM; Ruiz C; Lussier D; Le BK; Angel N; Smith M; Hwang CB; Khatib R; Jenkins J; Adams K; Getcher J; Tham F; Chen ZG; Wilson EH; Eichler JF
    J Inorg Biochem; 2014 Dec; 141():121-131. PubMed ID: 25243390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthesis, chemical and biological properties of dichlorido(azpy)gold(III) chloride (azpy=2-(phenylazo)pyridine) and the gold-induced conversion of the azpy ligand to the chloride of the novel tricyclic pyrido[2,1-c][1,2,4]benzotriazin-11-ium cation.
    Garza-Ortiz A; den Dulk H; Brouwer J; Kooijman H; Spek AL; Reedijk J
    J Inorg Biochem; 2007 Nov; 101(11-12):1922-30. PubMed ID: 17637477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of gold(III)-dithiocarbamato derivatives on prostate cancer cells and xenografts.
    Cattaruzza L; Fregona D; Mongiat M; Ronconi L; Fassina A; Colombatti A; Aldinucci D
    Int J Cancer; 2011 Jan; 128(1):206-15. PubMed ID: 20209498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
    Hu Z; Zeng Q; Zhang B; Liu H; Wang W
    Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway.
    Wang R; Ma L; Weng D; Yao J; Liu X; Jin F
    Oncol Rep; 2016 May; 35(5):3075-83. PubMed ID: 26987028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-dependent functionalization of wild-type and mutant p53 in cisplatin-resistant human ovarian tumor cells.
    Bhatt M; Ivan C; Xie X; Siddik ZH
    Oncotarget; 2017 Feb; 8(7):10905-10918. PubMed ID: 28038466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterisation and biological properties of gold(III) compounds with modified bipyridine and bipyridylamine ligands.
    Casini A; Diawara MC; Scopelliti R; Zakeeruddin SM; Grätzel M; Dyson PJ
    Dalton Trans; 2010 Mar; 39(9):2239-45. PubMed ID: 20162197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gold(III)-dithiocarbamato peptidomimetics in the forefront of the targeted anticancer therapy: preclinical studies against human breast neoplasia.
    Nardon C; Schmitt SM; Yang H; Zuo J; Fregona D; Dou QP
    PLoS One; 2014; 9(1):e84248. PubMed ID: 24392119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent In Vitro and In Vivo Anticancer Activity of New Bipyridine and Bipyrimidine Gold (III) Dithiocarbamate Derivatives.
    Altaf M; Casagrande N; Mariotto E; Baig N; Kawde AN; Corona G; Larcher R; Borghese C; Pavan C; Seliman AA; Aldinucci D; Isab AA
    Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30987271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin resistance in human cervical, ovarian and lung cancer cells.
    Chen J; Solomides C; Parekh H; Simpkins F; Simpkins H
    Cancer Chemother Pharmacol; 2015 Jun; 75(6):1217-27. PubMed ID: 25894720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.
    Ronconi L; Giovagnini L; Marzano C; Bettìo F; Graziani R; Pilloni G; Fregona D
    Inorg Chem; 2005 Mar; 44(6):1867-81. PubMed ID: 15762713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Walsuronoid B induces mitochondrial and lysosomal dysfunction leading to apoptotic rather than autophagic cell death via ROS/p53 signaling pathways in liver cancer.
    Geng YD; Zhang C; Lei JL; Yu P; Xia YZ; Zhang H; Yang L; Kong LY
    Biochem Pharmacol; 2017 Oct; 142():71-86. PubMed ID: 28673807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro.
    Kozubík A; Horváth V; Svihálková-Sindlerová L; Soucek K; Hofmanová J; Sova P; Kroutil A; Zák F; Mistr A; Turánek J
    Biochem Pharmacol; 2005 Feb; 69(3):373-83. PubMed ID: 15652229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the potential of gold(III) cyclometallated compounds as cytotoxic agents: variations on the C^N theme.
    Bertrand B; Spreckelmeyer S; Bodio E; Cocco F; Picquet M; Richard P; Le Gendre P; Orvig C; Cinellu MA; Casini A
    Dalton Trans; 2015 Jul; 44(26):11911-8. PubMed ID: 26060937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bithionol inhibits ovarian cancer cell growth in vitro - studies on mechanism(s) of action.
    Ayyagari VN; Brard L
    BMC Cancer; 2014 Feb; 14():61. PubMed ID: 24495391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gold(III) dithiocarbamate derivatives for the treatment of cancer: solution chemistry, DNA binding, and hemolytic properties.
    Ronconi L; Marzano C; Zanello P; Corsini M; Miolo G; Maccà C; Trevisan A; Fregona D
    J Med Chem; 2006 Mar; 49(5):1648-57. PubMed ID: 16509581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.